Article

(2021) The Association of Age, Sex, and RT-PCR Results with the Lymphocyte and Neutrophil Counts in SARS-CoV-2 Infection: A Cross-sectional Analysis of 1450 Iranian Patients with COVID-19. Iranian Journal of Allergy Asthma and Immunology. pp. 129-139. ISSN 1735-1502

(2021) Evaluation of Factors Affecting the Strategic Purchasing of Medicines in the Iran Armed Forces Health Insurance Organization. Journal of Military Medicine. pp. 610-617. ISSN 17351537 (ISSN)

(2021) Evaluation of pharmacotherapy protocols for covid 19 patients in baqiyatallah hospital and their outcomes. Bulletin of Pharmaceutical Sciences. Assiut. pp. 89-97. ISSN 11100052 (ISSN)

(2020) Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfusion and Apheresis Science. p. 5. ISSN 1473-0502

(2020) Management of COVID-19 Virus Infection by Convalescent Plasma. Iranian Journal of Allergy Asthma and Immunology. pp. 3-6. ISSN 1735-1502

(2019) Gentamicin-Loaded Chitosan Nanoparticles Improve Its Therapeutic Effects on Brucella-Infected J774A.1 Murine Cells. Galen Medical Journal. p. 9. ISSN 2588-2767

(2018) IMPACT OF ECONOMIC SANCTIONS ON ACCESS TO NONCOMMUNICABLE DISEASES MEDICINES IN THE ISLAMIC REPUBLIC OF IRAN. Value in Health. S64-S64. ISSN 1098-3015

(2017) Application of nanoparticles drug delivery systems in the treatment of intracellular bacterial infections. Minerva Biotecnologica. pp. 156-165. ISSN 1120-4826

(2017) Trends in Iran Pharmaceutical Market. Iran J Pharm Res. pp. 1-7. ISSN 1735-0328 (Print) 1726-6882

(2016) Cost components of treatment protocols of haemophilia patients with inhibitors using bypassing agents in Iran. Iranian Journal of Pharmaceutical Sciences. pp. 85-90. ISSN 17352444 (ISSN)

(2016) Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven (TM)) and Activated Prothrombin Complex Concentrates (FEIBA (TM)) to Treat Hemophilia A Patients with Inhibitors in Iran. Iranian Journal of Pharmaceutical Research. pp. 669-677. ISSN 1735-0328

(2016) Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study. Journal of Research in Pharmacy Practice. pp. 234-237. ISSN 2319-9644

(2016) Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran. Int J Hematol Oncol Stem Cell Res. pp. 224-231. ISSN 2008-3009 (Print) 2008-2207

(2016) Newly defined role of pharmacoeconomics in Iran national medicine policy. Shiraz E Medical Journal. ISSN 17351391 (ISSN)

(2015) A review of pharmaceutical policies in response to economic crises and sanctions. Journal of Research in Pharmacy Practice. pp. 115-122. ISSN 2319-9644

(2014) Access to alternative biopharmaceuticals in low-and middle-income countries. GaBI Journal. pp. 164-165. ISSN 20336403 (ISSN)

(2014) Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors. Iranian Red Crescent Medical Journal. p. 6. ISSN 2074-1804

(2014) Evaluation of heavy metals contamination in Iranian foodstuffs: canned tomato paste and tomato sauce (ketchup). Food Additives & Contaminants Part B-Surveillance. pp. 74-78. ISSN 1939-3210

(2014) A system dynamics model for national drug policy. Daru-Journal of Pharmaceutical Sciences. p. 13.

(2013) Impacts of international sanctions on Iranian pharmaceutical market. Daru-Journal of Pharmaceutical Sciences. p. 3. ISSN 1560-8115

(2013) Implementing the essential medicine concept in the country with the highest GDP per capita in the world. Eastern Mediterranean Health Journal. pp. 94-96. ISSN 1020-3397

(2013) Implications of pharmacoeconomics for Iran national health system. Iranian Journal of Pharmaceutical Sciences. pp. 81-85. ISSN 17352444 (ISSN)

(2012) Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry. Daru-Journal of Pharmaceutical Sciences. p. 4. ISSN 2008-2231

(2012) Cost Assessment of Implementation of Immune Tolerance Induction in Iran. Value Health Reg Issues. pp. 54-58. ISSN 2212-1099

(2012) Cost effectiveness of Iran national plasma contract fractionation program. Daru-Journal of Pharmaceutical Sciences. p. 6.

(2012) Current challenges and future achievements of blood transfusion service in Afghanistan. Transfusion and Apheresis Science. pp. 127-132. ISSN 1473-0502

(2012) Overview of Blood Transfusion System of Iran: 2002-2011. Iranian Journal of Public Health. pp. 89-93. ISSN 2251-6085

(2012) Scientific Apartheid. Hepatitis Monthly. pp. 158-159. ISSN 1735-143X

(2011) Blood safety concerns in the Eastern Mediterranean region. Hepatitis Monthly. pp. 422-426. ISSN 1735-143X

(2011) Commentary on: Effectiveness of confidential unit exclusion option in blood transfusion services needs re-evaluation. Hepatitis Monthly. pp. 295-296. ISSN 1735-143X

(2011) Implications of Confidential Unit Exclusion in Providing Sufficient Safe Blood for the National Health System. Hepatitis Monthly. pp. 878-880. ISSN 1735-143X

(2011) Social consequences of infected haemophilia cases in the Islamic Republic of Iran. Eastern Mediterranean Health Journal. pp. 552-556. ISSN 10203397 (ISSN)

(2010) Heavy Metals Contamination of Table Salt Consumed in Iran. Iranian Journal of Pharmaceutical Research. pp. 129-132. ISSN 1735-0328

(2010) INTERVENTIONS TO CONTROL AFLATOXIN CONTAMINATION IN PISTACHIO NUTS: IRAN EXPERIENCE. Journal of Food Safety. pp. 382-397. ISSN 0149-6085

(2010) Improving availability and affordability of plasma-derived medicines. Biologicals. pp. 81-86. ISSN 1045-1056

(2009) Availability, affordability, and prescribing pattern of medicines in Sudan. Pharmacy World & Science. pp. 209-215. ISSN 0928-1231

(2009) Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines. Transfusion Medicine. pp. 363-368. ISSN 0958-7578

(2009) Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience. Haemophilia. pp. 487-493. ISSN 1351-8216

(2007) Availability of blood components and plasma derived medicines in Iran. Transfusion and Apheresis Science. pp. 3-7. ISSN 1473-0502

(2007) Fatalities following skin exposure to arsenic. Clinical Toxicology. pp. 965-967. ISSN 1556-3650

(2007) Incidence of aflatoxins in Iran pistachio nuts. Food and Chemical Toxicology. pp. 812-816. ISSN 0278-6915

(2006) Injectable diclofenac: A painful shot into Iran's health system. Social Science & Medicine. pp. 1597-1601. ISSN 0277-9536

(2005) Effect of roasting on degradation of Aflatoxins in contaminated pistachio nuts. Food and Chemical Toxicology. pp. 1135-1139. ISSN 0278-6915

(2002) Bioequivalency study of diazoxide using a rapid HPLC method. Biomedical Research. pp. 141-143. ISSN 0970938X (ISSN)

Book Section

(2009) The selection and use of essential medicines. In: World Health Organization - Technical Report Series. , pp. 1-242. ISBN 05123054 (ISSN); 9789241209588 (ISBN)